Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Sep 8, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $29.29 thousand as of September 8, 2026. Its market cap has decreased by -99.83% in one year.
Market Cap
29.29K
Enterprise Value
-1.99M
Revenue
52.63M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
ChartMarket Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 29.29K, a decrease of -99.98%. That is a compound annual growth rate of -91.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 29.29K | -98.37% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U.S. Stem Cell | 66.15K |
| Nascent Biotech | 51.85K |
| Itoco | 42.82K |
| Entia Biosciences | 27.25K |
| Nymox Pharmaceutical | 21.01K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |